Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Queensland Health
Teva
US Department of Justice
Covington
Farmers Insurance
Cantor Fitzgerald
Harvard Business School
US Army

Generated: October 20, 2017

DrugPatentWatch Database Preview

BUTAPAP Drug Profile

« Back to Dashboard

Which patents cover Butapap, and when can generic versions of Butapap launch?

Butapap is a drug marketed by Mikart and is included in two NDAs.

The generic ingredient in BUTAPAP is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.

Summary for Tradename: BUTAPAP

US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list5
Bulk Api Vendors: see list99
Patent Applications: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BUTAPAP at DailyMed

Pharmacology for Tradename: BUTAPAP

Ingredient-typeBarbiturates
Drug ClassBarbiturate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mikart
BUTAPAP
acetaminophen; butalbital
TABLET;ORAL089987-001Oct 26, 1992AARXNoYes► Subscribe► Subscribe► Subscribe
Mikart
BUTAPAP
acetaminophen; butalbital
TABLET;ORAL089988-001Oct 26, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Moodys
Daiichi Sankyo
UBS
Chinese Patent Office
Dow
Cipla
McKinsey
Chubb
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot